OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

One-Year Sustained Cellular and Humoral Immunities in Coronavirus Disease 2019 (COVID-19) Convalescents
Jie Zhang, Hao Lin, Beiwei Ye, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e1072-e1081
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study
Li Guo, Geng Wang, Yeming Wang, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 5, pp. e348-e356
Open Access | Times Cited: 148

Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after infection
Yang Yang, Minghui Yang, Yun Peng, et al.
Nature Microbiology (2022) Vol. 7, Iss. 3, pp. 423-433
Open Access | Times Cited: 104

T cell immune evasion by SARS-CoV-2 JN.1 escapees targeting two cytotoxic T cell epitope hotspots
Jinmin Tian, Bingli Shang, Jianing Zhang, et al.
Nature Immunology (2025)
Closed Access | Times Cited: 1

Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients
Maddalena Peghin, Maria De Martino, Alvisa Palese, et al.
Clinical Microbiology and Infection (2022) Vol. 28, Iss. 8, pp. 1140-1148
Open Access | Times Cited: 48

The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
Esther Moga, Elionor Lynton-Pons, Peré Domingo
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44

Durability and cross-reactive immune memory to SARS-CoV-2 in individuals 2 years after recovery from COVID-19: a longitudinal cohort study
Li Guo, Qiao Zhang, Xiaoying Gu, et al.
The Lancet Microbe (2023) Vol. 5, Iss. 1, pp. e24-e33
Open Access | Times Cited: 25

Impact of Prior COVID-19 Immunization and/or Prior Infection on Immune Responses and Clinical Outcomes
Achilleas Livieratos, Charalambos Gogos, Karolina Akinosoglou
Viruses (2024) Vol. 16, Iss. 5, pp. 685-685
Open Access | Times Cited: 9

Neutralizing Antibodies and Cellular Immune Responses Against SARS-CoV-2 Sustained One and a Half Years After Natural Infection
Lina Yan, Panpan Liu, Xu-gui Li, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 29

Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort
Dominik Menges, Kyra D. Zens, Tala Ballouz, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 25

Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis
Ana Zabalza, Georgina Arrambide, Paula Tagliani, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 9, Iss. 2
Open Access | Times Cited: 19

SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection
Arbor G. Dykema, Boyang Zhang, Bezawit A. Woldemeskel, et al.
EBioMedicine (2022) Vol. 80, pp. 104048-104048
Open Access | Times Cited: 18

Seeing the T cell Immunity of SARS-CoV-2 and SARS-CoV: Believing the Epitope-Oriented Vaccines
Can Yue, Pengyan Wang, Jinmin Tian, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 13, pp. 4052-4060
Open Access | Times Cited: 11

A 1-year longitudinal study on COVID-19 convalescents reveals persistence of anti-SARS-CoV-2 humoral and cellular immunity
Li Yang, Xi Wang, Xu-Rui Shen, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 902-913
Open Access | Times Cited: 15

T cells in SARS-CoV-2 infection and vaccination
Arthur P. Young
Therapeutic Advances in Vaccines and Immunotherapy (2022) Vol. 10
Open Access | Times Cited: 15

Persistent Antibody Responses Up to 18 Months After Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Pyoeng Gyun Choe, Jisu Hong, Jiyoung Park, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 7, pp. 1224-1230
Open Access | Times Cited: 14

SARS-CoV-2 T Cell Immunity Responses following Natural Infection and Vaccination
Vassiliki Pitiriga, Myrto Papamentzelopoulou, Kanella E. Konstantinakou, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1186-1186
Open Access | Times Cited: 8

A systemic review of T-cell epitopes defined from the proteome of SARS-CoV-2
Xiaoxiao Jin, Xiaotao Liu, Chuanlai Shen
Virus Research (2022) Vol. 324, pp. 199024-199024
Open Access | Times Cited: 13

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants
Yuntao Zhang, Wenjie Tan, Zhiyong Lou, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1149-1149
Open Access | Times Cited: 11

Proteomics Investigation of Diverse Serological Patterns in COVID-19
Xiao Liang, Rui Sun, Jing Wang, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 2, pp. 100493-100493
Open Access | Times Cited: 5

Sustained abnormality with recovery of COVID-19 convalescents: a 2-year follow-up study
Hao Lin, Xueyuan Liu, Heqiang Sun, et al.
Science Bulletin (2022) Vol. 67, Iss. 15, pp. 1556-1561
Open Access | Times Cited: 9

Neutralizing-antibody response to SARS-CoV-2 for 12 months after the COVID-19 workplace outbreaks in Japan
Azumi Ishizaki, Xiuqiong Bi, Quynh Thi Nguyen, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0273712-e0273712
Open Access | Times Cited: 9

Effect of Corticosteroids on Long-Term Humoral and Memory T-Cell Responses in Follow-Up Visit of Hospitalized Patients With COVID-19
Yeming Wang, Guo Li, Guohui Fan, et al.
CHEST Journal (2024) Vol. 166, Iss. 2, pp. 281-293
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top